Media

WASHINGTON, D.C. – This week, Reese’s Law, bipartisan legislation co-led by Reps. Robin Kelly (D-IL), Jodey Arrington (R-TX) and Ted Lieu (D-CA) to protect children from ingesting button cell batteries passed the Senate. The legislation will now go to President Biden’s desk for signature. Reese’s Law is named for Reese Hamsmith, an 18-month-old child who tragically passed away after ingesting a button cell battery.

WASHINGTON, D.C. – Today, Congresswoman Robin Kelly voted to pass H.R. 1808, Assault Weapons Ban Act of 2022, which passed by a vote of 217 to 213. The Assault Weapons Ban Act restores and updates the prior assault weapons ban that kept weapons of war out of our communities for a decade before Republicans opposed its renewal. 

WASHINGTON, D.C. – Last night, Reese’s Law, bipartisan legislation co-led by Reps. Robin Kelly (D-IL), Jodey Arrington (R-TX) and Ted Lieu (D-CA) to protect children from ingesting button cell batteries passed the House. Reese’s Law is named for Reese Hamsmith, an 18-month-old child who tragically passed away after ingesting a button cell battery.

WASHINGTON, DC – Today, Rep. Robin Kelly (IL-02) voted to pass H.R. 8294, a package of six government funding bills, which focuses on helping families and communities across America. The transformative investments in the bill will lower the cost of living, create good-paying American jobs, lift up working families and support small businesses. The package also includes several of Rep. Kelly’s FY2023 Community Project Funding requests.

WASHINGTON, DC – Today, Congresswoman Robin Kelly (D-IL), Chair of the Congressional Black Caucus Health Braintrust, led a majority of the CBC in a letter to Federal Drug Administration (FDA) Commissioner Robert Califf expressing strong support for the FDA’s

WASHINGTON, D.C. – Today, Congresswoman Robin L. Kelly (IL-02) and Chicago Mayor Lori E. Lightfoot held a press conference with gun violence prevention advocates to underscore the lifesaving impact the recently-passed Bipartisan Safer Communities Act will have on Chicago. Rep.

WASHINGTON, DC – Today, the House Energy and Commerce Health Subcommittee held a hearing on H.R. 7845, Congresswoman Robin Kelly’s (IL-02) NIH Clinical Trial Diversity Act. This bipartisan legislation builds upon the NIH’s current policies to enhance the inclusion of women, racially and ethnically diverse individuals and people across the lifespan in all NIH-funded trials.